{"search_session":{},"preferences":{"l":"ar","queryLanguage":"ar"},"patentId":"064-202-534-822-568","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"064-202-534-822-568","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8906,"type":"PATENT","title":"Univ Pennsylvania Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":24238,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8221,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search applicants and owners= \"Univ Pennsylvania\", \"Pennsylvania Univ\", \"Univ Penns*\", \"Penn* Univ\", \"University of Pennsylvania\", \"Pennsylvania University\".
Select more for logical variants
Add to collection
Total patent:
Search applicants and owners= \"Univ Pennsylvania\", \"Pennsylvania Univ\", \"Univ Penns*\", \"Penn* Univ\", \"University of Pennsylvania\", \"Pennsylvania University\".
Select more for logical variants
Add to collection
Total patent:
an N-terminal or C-terminal truncation of about 50 amino acids in length of the AdPan6 hexon protein sequence of SEQ ID NO:7;
amino acid residues 125 to 443;
amino acid residues 138 to 441;
amino acid residues 138 to 163;
amino acid residues 170 to 176; and
amino acid residues 404 to 430, with reference to SEQ ID NO:7."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The recombinant adenovirus according to any one of claims 6 to 11, wherein the adenovirus comprises adenoviral nucleic acid sequences selected from one or more of the group consisting of:
5' inverted terminal repeat (ITR) sequences;
the E3 region, or a fragment thereof selected from the group consisting of E3 ORF1, E3 ORF2, E3 ORF3, E3 ORF4, E3 ORF5, E3 ORF6, E3 ORF7, E3 ORF8, and E3 ORF9;
the E4 region, or a fragment thereof selected from the group consisting of E4 ORF7, E4 ORF6, E4 ORF4, E4 ORF3, E4 ORF2, and E4 ORF1; and
the 3' ITR,of Pan6 SEQ ID NO:5 or sequence complementary thereto."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The recombinant adenovirus according to claim 12 comprising at least one simian capsid protein selected from:
a penton protein of Pan6 SEQ ID NO:6; and
a fiber protein of Pan6 SEQ ID NO:8."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["An isolated host cell comprising a recombinant adenovirus according to any one of claims 6 to 13."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["A composition comprising a recombinant adenovirus according to any one of claims 6 to 13 and a pharmaceutically acceptable carrier."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["Use of a recombinant adenovirus of any one of claims 6 to 13 for the manufacture of a medicament formulated for eliciting an immune response against an infective agent in a mammalian host, wherein said heterologous gene encodes an antigen of the infective agent."],"number":16,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}